Company profile

EDELRIS

We focus our effort to create value for your projects.

Industry
Biotechnology Research
Employees
75
Headquarters
Lyon, Auvergne-Rhône-Alpes
Founded
2005
LinkedIn followers
8,255
Office locations
1

EDELRIS company summary

EDELRIS is a company in the Biotechnology Research industry, headquartered in Lyon, Auvergne-Rhône-Alpes, founded in 2005. On LinkedIn the company has around 75 employees and 8,255 followers. Its listed specialties include Natural Product like Compound Collections, Fragment libraries, DNA encoded libraries, Compound screening, Affinity Screening - Mass Spectrometry.

What technology does EDELRIS use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About EDELRIS

EDELRIS is a pioneering company dedicated to the design and chemical synthesis of innovative natural product-like screening Libraries, medicinal chemistry Hit-to-Lead / Lead Optimization projects, Custom Synthesis, and Affinity screening-Mass Spectrometry (AS-MS). Aiming at the acceleration of the lead discovery and optimization process in pharma and biotech research organizations, EDELRIS uses its recognized chemistry and screening expertise in drug discovery to provide novelty to its clients and partners. Our unique and first-in-class NP-like, easily tractable screening libraries (Fragments, Covalent binders, conventional HTS & DEL) now contain +2M in-house synthesized compounds, with built-in hit-to-lead optimization capabilities. Our clients can review these libraries on an exclusive or non-exclusive basis. EDELRIS has a wide range of services and provides state-of-the-art target qualification (protein and RNA), screening, and hit identification capacities by applying our in-house AS-MS (Affinity Selection – Mass Spectrometry) technologies. We have a comprehensive chemical analysis department to support our broad portfolio of ongoing organic and medicinal chemistry projects, as well as screening campaigns. The EDELRIS team is capable of delivering innovative solutions to synthetic and medicinal chemistry challenges faced by our clients. When partnering with EDELRIS, we focus our efforts on creating value for your projects. In 2024, Edelris was integrated into the global Janvier Group Biosciences, expanding its capabilities and reach in the drug discovery field

Specialties

Natural Product like Compound CollectionsFragment librariesDNA encoded librariesCompound screeningAffinity Screening - Mass SpectrometryVirtual ScreeningSynthetic ChemistryOrganic ChemistryMedicinal ChemistryAnalytical ChemistryCovalent InhibitorsAS-MS

Where is EDELRIS located?

EDELRIS lists 1 location.

Lyon, Auvergne-Rhône-Alpes, FRHQ
60, Avenue Rockefeller

Compare companies similar to EDELRIS

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
EDELRIS
edelris.com
Biotechnology Research752005Lyon, Auvergne-Rhône-Alpes
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about EDELRIS

What does EDELRIS do?

EDELRIS is a pioneering company dedicated to the design and chemical synthesis of innovative natural product-like screening Libraries, medicinal chemistry Hit-to-Lead / Lead Optimization projects, Custom Synthesis, and Affinity screening-Mass Spectrometry (AS-MS). Aiming at the acceleration of the lead discovery and optimization process in pharma and biotech research organizations, EDELRIS uses its recognized chemistry and screening expertise in drug discovery to provide novelty to its clients and partners. Our unique and first-in-class NP-like, easily tractable screening libraries (Fragments, Covalent binders, conventional HTS & DEL) now contain +2M in-house synthesized compounds, with built-in hit-to-lead optimization capabilities. Our clients can review these libraries on an exclusive or non-exclusive basis. EDELRIS has a wide range of services and provides state-of-the-art target qualification (protein and RNA), screening, and hit identification capacities by applying our in-house AS-MS (Affinity Selection – Mass Spectrometry) technologies. We have a comprehensive chemical analysis department to support our broad portfolio of ongoing organic and medicinal chemistry projects, as well as screening campaigns. The EDELRIS team is capable of delivering innovative solutions to synthetic and medicinal chemistry challenges faced by our clients. When partnering with EDELRIS, we focus our efforts on creating value for your projects. In 2024, Edelris was integrated into the global Janvier Group Biosciences, expanding its capabilities and reach in the drug discovery field

How many employees does EDELRIS have?

EDELRIS has around 75 employees on LinkedIn.

Where is EDELRIS headquartered?

EDELRIS is headquartered in Lyon, Auvergne-Rhône-Alpes.

When was EDELRIS founded?

EDELRIS was founded in 2005.

Build a lead list from companies like EDELRIS

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.